Gary Glick, Keith Flaherty

What can a biotech en­tre­pre­neur and a top sci­en­tist come up with on a cou­ple of shared flights? Well...

Just weeks be­fore the pan­dem­ic hit the states, Gary Glick and Kei­th Fla­her­ty had a chance to spend 12 hours to­geth­er, talk­ing craft and trade on board shared flights as they head­ed to and from a board meet­ing to­geth­er.

It may have been the most fruit­ful 12 hours of Glick’s pro­duc­tive life. They cer­tain­ly found plen­ty to talk about.

Glick, a well known biotech en­tre­pre­neur and in­flam­ma­to­ry spe­cial­ist, had bumped up to ex­ec­u­tive chair at IFM Ther­a­peu­tics just weeks be­fore, af­ter run­ning through a slate of siz­able deals with some ma­jor phar­ma play­ers like No­var­tis.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.